DBV Technologies submits BLA to FDA for VIASKIN Peanut Patch
DBV Technologies announced the submission of a Biologics License Application to the U.S. FDA for the VIASKIN Peanut patch targeting children aged 4-7.
DBV Technologies announced the submission of a Biologics License Application to the U.S. FDA for the VIASKIN Peanut patch targeting children aged 4-7.